From what I’m reading there are many factors that determine the value of a PRV voucher such as how many were issued in that year how many are available on the market the companies looking to buy the PRV and if they are first to market with a drug that has major potential if their third the market with a similar drug the value goes down so depending on who wants to buy the PRV how many PRV‘s have been issued How big the sales potential is for the drug company wanting to buy the PRV their order as far as bringing the drug to market as well as many other factors
What I’m asking you is I have seen nothing stating that if a company sells a priority review voucher to another company that they have to partner with that company everything I’ve read says they can sell a priority review voucher to a company trying to beat out other companies to market or just expedite the time they get to market because it’s worth so many billions of dollars or so many hundreds of millions of dollars to beat their competitors but I haven’t seen one thing that says companies selling priority review vouchers are required to partner????So where did you hear that app because you’re kind of giving the assumption that any big company that buys her prior to review voucher will partner with us
News 
Market Data 
Discover 
